I'd have to look more closely at the first quarter 10-Q, but from what I recall, there is now very little left on the balance sheet of the type of instrument covered under that ASU, as that was the potentially toxic debt that used to cause wild swings in the P&L and was largely eliminated by February. As long as they don't issue any more of it, which fortunately they seem averse to doing, I don't think there will be any significant effects from that ASU on the statements going forward.